Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma

计划入组 60 人 · 首次发布于 2025 年 3 月 30 日

QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA

计划入组 43 人 · 首次发布于 2010 年 6 月 22 日

CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors

计划入组 108 人 · 首次发布于 2025 年 9 月 18 日

CEA ADC (Jiangsu hengrui)

VLI-02A

CEA-652

ADC Therapeutics

Switzerland

ADC Therapeutics America, Inc.

United States

Lophora ApS

Denmark

BeiGene Raises 2026 Revenue Guidance as Brukinsa Sales Momentum Continues, CEA ADC Data Slated for ESMO 2026

Orano Med and Roche Advance Novel Two-Step Radioimmunotherapy Targeting CEA-Positive Cancers

Induction of Cure in Early Arthritis (I CEA) Trial: Evaluating Treatment Strategies for Undifferentiated Arthritis